Dietary Patterns and Physical Activity Correlate With Total Cholesterol Independently of Lipid-Lowering Drugs and Antiretroviral Therapy in Aging People Living With Human Immunodeficiency Virus

被引:5
|
作者
Marzel, Alex [1 ,2 ]
Kouyos, Roger D. [1 ,2 ]
Reinschmidt, Sara [1 ]
Balzer, Katharina [1 ]
Garon, Fabienne [1 ]
Spitaleri, Monica [1 ]
Matthes, Nicolas [3 ]
Suter, Paolo [4 ]
Weber, Rainer [1 ]
Staehelin, Cornelia [5 ]
Lecompte, Thanh Doco [3 ]
Tarr, Philip [6 ,7 ]
Kovari, Helen [1 ]
机构
[1] Univ Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland
[2] Univ Zurich, Inst Med Virol, Zurich, Switzerland
[3] Univ Geneva, Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland
[4] Univ Zurich, Clin Internal Med, Zurich, Switzerland
[5] Univ Bern, Univ Hosp Berne, Div Infect Dis, Bern, Switzerland
[6] Univ Basel, Kantonsspital Baselland, Univ Dept Med, Bruderholz, Switzerland
[7] Univ Basel, Kantonsspital Baselland, Div Infect Dis & Hosp Epidemiol, Bruderholz, Switzerland
来源
OPEN FORUM INFECTIOUS DISEASES | 2018年 / 5卷 / 04期
基金
瑞士国家科学基金会;
关键词
aging; diet; HIV; physical activity; total cholesterol; CORONARY-HEART-DISEASE; 40; COUNTRIES; RISK; HIV; METAANALYSIS; INDIVIDUALS; ASSOCIATION; POPULATION; PRODUCTS; COHORT;
D O I
10.1093/ofid/ofy067
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Hypercholesterolemia is a well established risk factor for coronary heart disease and is highly prevalent among human immunodeficiency virus (HIV)-positive persons. Antiretroviral therapy (ART) can both directly modify total cholesterol and have drug-drug interactions with statins. This makes investigating modifiable behavioral predictors of total cholesterol a pertinent task. Methods. To explore the association between diet and physical activity with cross-sectionally measured total cholesterol, we administered a validated Food-Frequency-Questionnaire to participants of the Swiss HIV Cohort Study >= 45 years old. Linear mixed-effects models were applied to explore the associations between dietary patterns and physical activity with total cholesterol, after adjustment for clinical and demographic covariates. Results. In total, 395 patients were included. Forty percent (158 of 395) had elevated total cholesterol (> 5.2 mmol/L), and 41% (164 of 395) were not regularly physically active. In multivariable analysis, 2 factors were positively associated with total cholesterol; female sex (beta = 0.562; 95% confidence interval [CI], 0.229-0.896) and the combined consumption of meat, refined/milled grains, carbonated beverages, and coffee (beta = 0.243; 95% CI, 0.047-0.439). On the other hand, regular physical activity (beta = -0.381; 95% CI, -0.626 to -0.136), lipid-lowering drugs (beta = -0.443; 95% CI -0.691 to -0.196), ART containing tenofovir (beta = -0.336; 95% CI -0.554 to -0.118), and black ethnicity (beta = -0.967; 95% CI -1.524 to -0.410) exhibited a negative association. Conclusions. We found independent associations between certain dietary patterns and physical activity with total cholesterol. Increasing physical activity might achieve cardiovascular and other health benefits in HIV-positive individuals. The clinical relevance of the identified dietary patterns requires further investigation in prospective cohort studies and randomized controlled trials.
引用
收藏
页数:8
相关论文
共 6 条
  • [1] The physical activity levels among people living with human immunodeficiency virus/acquired immunodeficiency syndrome receiving high active antiretroviral therapy in Rwanda
    Frantz, J. M.
    Murenzi, A.
    SAHARA J-JOURNAL OF SOCIAL ASPECTS OF HIV-AIDS, 2013, 10 (3-4) : 113 - 118
  • [2] Effect of anthropometric and sociodemographic variables on physical activity levels of people living with human immunodeficiency virus/acquired immunodeficiency syndrome on highly active antiretroviral therapy
    Anikpe, Jane Nwanneka
    Chukwu, Aroh Joseph
    Edem, Ekom Ndifreke
    Elahmar, Adel A. E.
    Sinha, Sohini
    Arome, David
    TZU CHI MEDICAL JOURNAL, 2023, 35 (02): : 200 - 204
  • [3] Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active Antiretroviral therapy in patients with human immunodeficiency virus
    Nguyen, Scan I.
    Eaton, Susan A.
    Bain, Amy M.
    Rahman, Anita P.
    Payne, Kenna D.
    Bedimo, Roger
    Herrington, Jon D.
    Maclayton, Darego O.
    Rodriguez-Barradas, Maria C.
    Busti, Anthony J.
    PHARMACOTHERAPY, 2008, 28 (03): : 323 - 330
  • [4] Switch rates, time-to-switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital-claim database
    Ruzicka, Daniel J.
    Kuroishi, Naho
    Oshima, Nobuyuki
    Sakuma, Ryuta
    Naito, Toshio
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [5] Switch rates, time-to-switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital-claim database
    Daniel J. Ruzicka
    Naho Kuroishi
    Nobuyuki Oshima
    Ryuta Sakuma
    Toshio Naito
    BMC Infectious Diseases, 19
  • [6] Comedication prescription patterns and potential for drug-drug interactions with antiretroviral therapy in people living with human immunodeficiency virus type 1 infection in Germany
    Lopes, Sara
    O'Day, Ken
    Meyer, Kellie
    Van Stiphout, Joris
    Punekar, Yogesh
    Radford, Matthew
    Haas, Jennifer Scarlet
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (03) : 270 - 278